Engagement of the private pharmaceutical sector for TB control: rhetoric or reality?
Background Private-sector retail drug outlets are often the first point of contact for common health ailments, including tuberculosis (TB). Systematic reviews on public-private mix (PPM) interventions for TB did not perform in-depth reviews specifically on engaging retail drug outlets and related st...
Main Authors: | Niranjan Konduri, Emily Delmotte, Edmund Rutta |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-12-01
|
Series: | Journal of Pharmaceutical Policy and Practice |
Subjects: | |
Online Access: | http://dx.doi.org/10.1186/s40545-016-0093-3 |
Similar Items
-
Engaging the Private Health Service Delivery Sector for TB Care in India—Miles to Go!
by: Rakesh P. Suseela, et al.
Published: (2023-05-01) -
PRIVATIZING MALAYSIA: Rents, Rhetoric, Realities/
by: Jomo K. S., (Jomo Kwame Sundaram), editor
Published: (2019) -
Finding the right balance: implementation of public–private partnership in artemisinin-based combination therapy provision in Manokwari, Indonesia
by: Astri Ferdiana, et al.
Published: (2021-12-01) -
An assessment of the malaria-related knowledge and practices of Tanzania’s drug retailers: exploring the impact of drug store accreditation
by: Rebecca Thomson, et al.
Published: (2018-03-01) -
TB and COVID – Public and private health sectors adapt to a new reality
by: Joel Shyam Klinton, et al.
Published: (2020-12-01)